Why the study?
Does the Triglyceride-Glucose Index predict long-term Major Adverse Cardiovascular Events in Turkish patients with high cardiovascular risk without prior cardiovascular disease?
Does the Triglyceride-Glucose Index predict long-term Major Adverse Cardiovascular Events in Turkish patients with high cardiovascular risk without prior cardiovascular disease?
The TyG index may serve as a useful biomarker for predicting long-term MACE in high-risk primary prevention patients.
May aid risk stratification in high-risk primary prevention; leaves open incremental value over standard scores in prospective validation.
The TyG index was demonstrated to be an independent predictor of long-term MACE occurrence in patients with high cardiovascular risk who had not been previously diagnosed with cardiovascular disease.
No takes yet. Share an insight, caveat, or question.
Hayıroğlu et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: